Susquehanna International Group, LLP Journey Medical Corp Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Journey Medical Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 18,722 shares of DERM stock, worth $93,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,722Holding current value
$93,235% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding DERM
# of Institutions
41Shares Held
4.66MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.73MShares$8.59 Million0.53% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.31 Million0.36% of portfolio
-
Cambridge Investment Research Advisors, Inc.328KShares$1.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.62 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny236KShares$1.18 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $57.8M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...